nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Dacarbazine—pancreatic cancer	0.439	0.616	CbGbCtD
Furosemide—ABCC2—Tamoxifen—pancreatic cancer	0.0574	0.0804	CbGbCtD
Furosemide—ABCC2—Irinotecan—pancreatic cancer	0.0441	0.0618	CbGbCtD
Furosemide—ABCC2—Docetaxel—pancreatic cancer	0.0323	0.0453	CbGbCtD
Furosemide—ABCC2—Sunitinib—pancreatic cancer	0.0321	0.0451	CbGbCtD
Furosemide—ALB—Erlotinib—pancreatic cancer	0.0304	0.0426	CbGbCtD
Furosemide—ALB—Irinotecan—pancreatic cancer	0.0275	0.0385	CbGbCtD
Furosemide—ALB—Fluorouracil—pancreatic cancer	0.0263	0.0369	CbGbCtD
Furosemide—ABCC2—Doxorubicin—pancreatic cancer	0.0241	0.0337	CbGbCtD
Furosemide—ABCC2—bile duct—pancreatic cancer	0.00935	0.191	CbGeAlD
Furosemide—ABCC2—bile—pancreatic cancer	0.00719	0.147	CbGeAlD
Furosemide—CA9—gall bladder—pancreatic cancer	0.00414	0.0845	CbGeAlD
Furosemide—CA9—islet of Langerhans—pancreatic cancer	0.00271	0.0554	CbGeAlD
Furosemide—SLCO2A1—islet of Langerhans—pancreatic cancer	0.00213	0.0435	CbGeAlD
Furosemide—ALB—gall bladder—pancreatic cancer	0.00213	0.0435	CbGeAlD
Furosemide—PGD—islet of Langerhans—pancreatic cancer	0.0019	0.0388	CbGeAlD
Furosemide—CA7—digestive system—pancreatic cancer	0.00185	0.0379	CbGeAlD
Furosemide—CA9—digestive system—pancreatic cancer	0.00163	0.0333	CbGeAlD
Furosemide—CA2—gall bladder—pancreatic cancer	0.00157	0.0321	CbGeAlD
Furosemide—SLCO2A1—pancreas—pancreatic cancer	0.0015	0.0306	CbGeAlD
Furosemide—SLC22A11—digestive system—pancreatic cancer	0.00143	0.0291	CbGeAlD
Furosemide—CA5B—pancreas—pancreatic cancer	0.00126	0.0258	CbGeAlD
Furosemide—CA4—islet of Langerhans—pancreatic cancer	0.00124	0.0254	CbGeAlD
Furosemide—CA12—digestive system—pancreatic cancer	0.0012	0.0246	CbGeAlD
Furosemide—PGD—digestive system—pancreatic cancer	0.00114	0.0233	CbGeAlD
Furosemide—CA1—pancreas—pancreatic cancer	0.00112	0.0228	CbGeAlD
Furosemide—CA2—islet of Langerhans—pancreatic cancer	0.00103	0.021	CbGeAlD
Furosemide—CA1—digestive system—pancreatic cancer	0.000954	0.0195	CbGeAlD
Furosemide—ABCC2—digestive system—pancreatic cancer	0.000785	0.016	CbGeAlD
Furosemide—CA4—digestive system—pancreatic cancer	0.000746	0.0152	CbGeAlD
Furosemide—CA2—pancreas—pancreatic cancer	0.000724	0.0148	CbGeAlD
Furosemide—CA2—digestive system—pancreatic cancer	0.000618	0.0126	CbGeAlD
Furosemide—SLC22A5—digestive system—pancreatic cancer	0.000608	0.0124	CbGeAlD
Furosemide—Vomiting—Erlotinib—pancreatic cancer	0.000216	0.00102	CcSEcCtD
Furosemide—Somnolence—Irinotecan—pancreatic cancer	0.000215	0.00102	CcSEcCtD
Furosemide—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000215	0.00102	CcSEcCtD
Furosemide—Headache—Tamoxifen—pancreatic cancer	0.000215	0.00102	CcSEcCtD
Furosemide—Rash—Erlotinib—pancreatic cancer	0.000214	0.00102	CcSEcCtD
Furosemide—Dermatitis—Erlotinib—pancreatic cancer	0.000214	0.00102	CcSEcCtD
Furosemide—Angiopathy—Docetaxel—pancreatic cancer	0.000214	0.00101	CcSEcCtD
Furosemide—Dehydration—Epirubicin—pancreatic cancer	0.000213	0.00101	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000213	0.00101	CcSEcCtD
Furosemide—Immune system disorder—Docetaxel—pancreatic cancer	0.000213	0.00101	CcSEcCtD
Furosemide—Headache—Erlotinib—pancreatic cancer	0.000213	0.00101	CcSEcCtD
Furosemide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000212	0.00101	CcSEcCtD
Furosemide—Asthenia—Sunitinib—pancreatic cancer	0.000211	0.001	CcSEcCtD
Furosemide—Decreased appetite—Irinotecan—pancreatic cancer	0.00021	0.000999	CcSEcCtD
Furosemide—Arrhythmia—Docetaxel—pancreatic cancer	0.00021	0.000999	CcSEcCtD
Furosemide—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00021	0.000996	CcSEcCtD
Furosemide—Somnolence—Gemcitabine—pancreatic cancer	0.00021	0.000995	CcSEcCtD
Furosemide—Hypokalaemia—Epirubicin—pancreatic cancer	0.000209	0.000992	CcSEcCtD
Furosemide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000209	0.000992	CcSEcCtD
Furosemide—Fatigue—Irinotecan—pancreatic cancer	0.000209	0.000991	CcSEcCtD
Furosemide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000208	0.000988	CcSEcCtD
Furosemide—Pruritus—Sunitinib—pancreatic cancer	0.000208	0.000987	CcSEcCtD
Furosemide—Constipation—Irinotecan—pancreatic cancer	0.000207	0.000983	CcSEcCtD
Furosemide—Pain—Irinotecan—pancreatic cancer	0.000207	0.000983	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000207	0.000982	CcSEcCtD
Furosemide—Somnolence—Fluorouracil—pancreatic cancer	0.000206	0.000978	CcSEcCtD
Furosemide—Erythema—Docetaxel—pancreatic cancer	0.000205	0.000973	CcSEcCtD
Furosemide—Malnutrition—Docetaxel—pancreatic cancer	0.000205	0.000973	CcSEcCtD
Furosemide—Decreased appetite—Gemcitabine—pancreatic cancer	0.000205	0.000973	CcSEcCtD
Furosemide—Nausea—Tamoxifen—pancreatic cancer	0.000204	0.000967	CcSEcCtD
Furosemide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000203	0.000966	CcSEcCtD
Furosemide—Fatigue—Gemcitabine—pancreatic cancer	0.000203	0.000965	CcSEcCtD
Furosemide—Muscular weakness—Epirubicin—pancreatic cancer	0.000202	0.000961	CcSEcCtD
Furosemide—Pain—Gemcitabine—pancreatic cancer	0.000202	0.000957	CcSEcCtD
Furosemide—Constipation—Gemcitabine—pancreatic cancer	0.000202	0.000957	CcSEcCtD
Furosemide—Nausea—Erlotinib—pancreatic cancer	0.000202	0.000957	CcSEcCtD
Furosemide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000201	0.000957	CcSEcCtD
Furosemide—Diarrhoea—Sunitinib—pancreatic cancer	0.000201	0.000954	CcSEcCtD
Furosemide—Dysgeusia—Docetaxel—pancreatic cancer	0.000201	0.000953	CcSEcCtD
Furosemide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.0002	0.00095	CcSEcCtD
Furosemide—Abdominal distension—Epirubicin—pancreatic cancer	0.0002	0.000949	CcSEcCtD
Furosemide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000199	0.000947	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000199	0.000945	CcSEcCtD
Furosemide—Pain—Fluorouracil—pancreatic cancer	0.000198	0.000941	CcSEcCtD
Furosemide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000198	0.00094	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—pancreatic cancer	0.000198	0.000938	CcSEcCtD
Furosemide—Muscle spasms—Docetaxel—pancreatic cancer	0.000197	0.000936	CcSEcCtD
Furosemide—Eosinophilia—Epirubicin—pancreatic cancer	0.000196	0.000933	CcSEcCtD
Furosemide—Pancreatitis—Epirubicin—pancreatic cancer	0.000195	0.000924	CcSEcCtD
Furosemide—Dizziness—Sunitinib—pancreatic cancer	0.000194	0.000922	CcSEcCtD
Furosemide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000194	0.000922	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000194	0.000921	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000193	0.000918	CcSEcCtD
Furosemide—Body temperature increased—Irinotecan—pancreatic cancer	0.000191	0.000908	CcSEcCtD
Furosemide—Abdominal pain—Irinotecan—pancreatic cancer	0.000191	0.000908	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000191	0.000908	CcSEcCtD
Furosemide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000191	0.000907	CcSEcCtD
Furosemide—Anaemia—Docetaxel—pancreatic cancer	0.000189	0.0009	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—pancreatic cancer	0.000187	0.00089	CcSEcCtD
Furosemide—Vomiting—Sunitinib—pancreatic cancer	0.000187	0.000887	CcSEcCtD
Furosemide—Body temperature increased—Gemcitabine—pancreatic cancer	0.000186	0.000885	CcSEcCtD
Furosemide—Rash—Sunitinib—pancreatic cancer	0.000185	0.00088	CcSEcCtD
Furosemide—Dermatitis—Sunitinib—pancreatic cancer	0.000185	0.000879	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—pancreatic cancer	0.000185	0.000878	CcSEcCtD
Furosemide—Urticaria—Fluorouracil—pancreatic cancer	0.000184	0.000874	CcSEcCtD
Furosemide—Headache—Sunitinib—pancreatic cancer	0.000184	0.000874	CcSEcCtD
Furosemide—Leukopenia—Docetaxel—pancreatic cancer	0.000183	0.000871	CcSEcCtD
Furosemide—Pollakiuria—Epirubicin—pancreatic cancer	0.000183	0.00087	CcSEcCtD
Furosemide—Body temperature increased—Fluorouracil—pancreatic cancer	0.000183	0.00087	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—pancreatic cancer	0.000182	0.000863	CcSEcCtD
Furosemide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000181	0.00086	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—pancreatic cancer	0.00018	0.000855	CcSEcCtD
Furosemide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000179	0.00085	CcSEcCtD
Furosemide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000178	0.000847	CcSEcCtD
Furosemide—Drowsiness—Epirubicin—pancreatic cancer	0.000177	0.00084	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000175	0.000833	CcSEcCtD
Furosemide—Nausea—Sunitinib—pancreatic cancer	0.000174	0.000829	CcSEcCtD
Furosemide—Renal failure—Epirubicin—pancreatic cancer	0.000174	0.000826	CcSEcCtD
Furosemide—Asthenia—Irinotecan—pancreatic cancer	0.000174	0.000824	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000173	0.000823	CcSEcCtD
Furosemide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000171	0.000811	CcSEcCtD
Furosemide—Dry mouth—Docetaxel—pancreatic cancer	0.000171	0.00081	CcSEcCtD
Furosemide—Sweating—Epirubicin—pancreatic cancer	0.00017	0.000805	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—pancreatic cancer	0.00017	0.000805	CcSEcCtD
Furosemide—Asthenia—Gemcitabine—pancreatic cancer	0.000169	0.000803	CcSEcCtD
Furosemide—Confusional state—Docetaxel—pancreatic cancer	0.000169	0.000801	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000168	0.000796	CcSEcCtD
Furosemide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000167	0.000795	CcSEcCtD
Furosemide—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000167	0.000794	CcSEcCtD
Furosemide—Pruritus—Gemcitabine—pancreatic cancer	0.000167	0.000792	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000166	0.000786	CcSEcCtD
Furosemide—Diarrhoea—Irinotecan—pancreatic cancer	0.000166	0.000786	CcSEcCtD
Furosemide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000165	0.000784	CcSEcCtD
Furosemide—Shock—Docetaxel—pancreatic cancer	0.000165	0.000782	CcSEcCtD
Furosemide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000164	0.000779	CcSEcCtD
Furosemide—Pruritus—Fluorouracil—pancreatic cancer	0.000164	0.000779	CcSEcCtD
Furosemide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000164	0.000778	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—pancreatic cancer	0.000164	0.000777	CcSEcCtD
Furosemide—Skin disorder—Docetaxel—pancreatic cancer	0.000162	0.000772	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000162	0.000771	CcSEcCtD
Furosemide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000161	0.000766	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—pancreatic cancer	0.000161	0.000764	CcSEcCtD
Furosemide—Dizziness—Irinotecan—pancreatic cancer	0.00016	0.00076	CcSEcCtD
Furosemide—Anorexia—Docetaxel—pancreatic cancer	0.000159	0.000757	CcSEcCtD
Furosemide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000159	0.000753	CcSEcCtD
Furosemide—Sweating—Doxorubicin—pancreatic cancer	0.000157	0.000745	CcSEcCtD
Furosemide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000157	0.000745	CcSEcCtD
Furosemide—Hypotension—Docetaxel—pancreatic cancer	0.000156	0.000742	CcSEcCtD
Furosemide—Urethral disorder—Epirubicin—pancreatic cancer	0.000156	0.000739	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000155	0.000735	CcSEcCtD
Furosemide—Vomiting—Irinotecan—pancreatic cancer	0.000154	0.000731	CcSEcCtD
Furosemide—Dizziness—Fluorouracil—pancreatic cancer	0.000153	0.000728	CcSEcCtD
Furosemide—Visual impairment—Epirubicin—pancreatic cancer	0.000153	0.000727	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000153	0.000725	CcSEcCtD
Furosemide—Rash—Irinotecan—pancreatic cancer	0.000153	0.000725	CcSEcCtD
Furosemide—Dermatitis—Irinotecan—pancreatic cancer	0.000152	0.000724	CcSEcCtD
Furosemide—Headache—Irinotecan—pancreatic cancer	0.000152	0.00072	CcSEcCtD
Furosemide—Paraesthesia—Docetaxel—pancreatic cancer	0.00015	0.000713	CcSEcCtD
Furosemide—Erythema multiforme—Epirubicin—pancreatic cancer	0.00015	0.000713	CcSEcCtD
Furosemide—Vomiting—Gemcitabine—pancreatic cancer	0.00015	0.000712	CcSEcCtD
Furosemide—Somnolence—Docetaxel—pancreatic cancer	0.000149	0.000706	CcSEcCtD
Furosemide—Rash—Gemcitabine—pancreatic cancer	0.000149	0.000706	CcSEcCtD
Furosemide—Dermatitis—Gemcitabine—pancreatic cancer	0.000148	0.000705	CcSEcCtD
Furosemide—Eye disorder—Epirubicin—pancreatic cancer	0.000148	0.000705	CcSEcCtD
Furosemide—Tinnitus—Epirubicin—pancreatic cancer	0.000148	0.000703	CcSEcCtD
Furosemide—Headache—Gemcitabine—pancreatic cancer	0.000148	0.000701	CcSEcCtD
Furosemide—Vomiting—Fluorouracil—pancreatic cancer	0.000147	0.0007	CcSEcCtD
Furosemide—Rash—Fluorouracil—pancreatic cancer	0.000146	0.000694	CcSEcCtD
Furosemide—Dermatitis—Fluorouracil—pancreatic cancer	0.000146	0.000693	CcSEcCtD
Furosemide—Decreased appetite—Docetaxel—pancreatic cancer	0.000145	0.000691	CcSEcCtD
Furosemide—Headache—Fluorouracil—pancreatic cancer	0.000145	0.000689	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000145	0.000689	CcSEcCtD
Furosemide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000144	0.000686	CcSEcCtD
Furosemide—Fatigue—Docetaxel—pancreatic cancer	0.000144	0.000685	CcSEcCtD
Furosemide—Angiopathy—Epirubicin—pancreatic cancer	0.000144	0.000684	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000144	0.000684	CcSEcCtD
Furosemide—Nausea—Irinotecan—pancreatic cancer	0.000144	0.000683	CcSEcCtD
Furosemide—Immune system disorder—Epirubicin—pancreatic cancer	0.000143	0.000681	CcSEcCtD
Furosemide—Pain—Docetaxel—pancreatic cancer	0.000143	0.000679	CcSEcCtD
Furosemide—Constipation—Docetaxel—pancreatic cancer	0.000143	0.000679	CcSEcCtD
Furosemide—Arrhythmia—Epirubicin—pancreatic cancer	0.000142	0.000674	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—pancreatic cancer	0.000142	0.000672	CcSEcCtD
Furosemide—Nausea—Gemcitabine—pancreatic cancer	0.00014	0.000665	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000139	0.00066	CcSEcCtD
Furosemide—Malnutrition—Epirubicin—pancreatic cancer	0.000138	0.000656	CcSEcCtD
Furosemide—Erythema—Epirubicin—pancreatic cancer	0.000138	0.000656	CcSEcCtD
Furosemide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000138	0.000655	CcSEcCtD
Furosemide—Nausea—Fluorouracil—pancreatic cancer	0.000138	0.000654	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—pancreatic cancer	0.000137	0.000652	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—pancreatic cancer	0.000137	0.000651	CcSEcCtD
Furosemide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000137	0.00065	CcSEcCtD
Furosemide—Flatulence—Epirubicin—pancreatic cancer	0.000136	0.000647	CcSEcCtD
Furosemide—Dysgeusia—Epirubicin—pancreatic cancer	0.000135	0.000643	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—pancreatic cancer	0.000133	0.000633	CcSEcCtD
Furosemide—Muscle spasms—Epirubicin—pancreatic cancer	0.000133	0.000631	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000133	0.00063	CcSEcCtD
Furosemide—Abdominal pain—Docetaxel—pancreatic cancer	0.000132	0.000628	CcSEcCtD
Furosemide—Body temperature increased—Docetaxel—pancreatic cancer	0.000132	0.000628	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—pancreatic cancer	0.000131	0.000623	CcSEcCtD
Furosemide—Vision blurred—Epirubicin—pancreatic cancer	0.00013	0.000619	CcSEcCtD
Furosemide—Erythema—Doxorubicin—pancreatic cancer	0.000128	0.000607	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—pancreatic cancer	0.000128	0.000607	CcSEcCtD
Furosemide—Anaemia—Epirubicin—pancreatic cancer	0.000128	0.000607	CcSEcCtD
Furosemide—Agitation—Epirubicin—pancreatic cancer	0.000127	0.000603	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—pancreatic cancer	0.000126	0.000599	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000125	0.000595	CcSEcCtD
Furosemide—Vertigo—Epirubicin—pancreatic cancer	0.000124	0.00059	CcSEcCtD
Furosemide—Leukopenia—Epirubicin—pancreatic cancer	0.000124	0.000588	CcSEcCtD
Furosemide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000123	0.000585	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—pancreatic cancer	0.000123	0.000584	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—pancreatic cancer	0.000121	0.000572	CcSEcCtD
Furosemide—Asthenia—Docetaxel—pancreatic cancer	0.00012	0.00057	CcSEcCtD
Furosemide—Pruritus—Docetaxel—pancreatic cancer	0.000118	0.000562	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—pancreatic cancer	0.000118	0.000561	CcSEcCtD
Furosemide—Agitation—Doxorubicin—pancreatic cancer	0.000118	0.000558	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000117	0.000555	CcSEcCtD
Furosemide—Dry mouth—Epirubicin—pancreatic cancer	0.000115	0.000547	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—pancreatic cancer	0.000115	0.000546	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—pancreatic cancer	0.000114	0.000544	CcSEcCtD
Furosemide—Diarrhoea—Docetaxel—pancreatic cancer	0.000114	0.000544	CcSEcCtD
Furosemide—Confusional state—Epirubicin—pancreatic cancer	0.000114	0.00054	CcSEcCtD
Furosemide—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000113	0.000536	CcSEcCtD
Furosemide—Shock—Epirubicin—pancreatic cancer	0.000111	0.000527	CcSEcCtD
Furosemide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000111	0.000525	CcSEcCtD
Furosemide—Dizziness—Docetaxel—pancreatic cancer	0.000111	0.000525	CcSEcCtD
Furosemide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00011	0.000525	CcSEcCtD
Furosemide—Skin disorder—Epirubicin—pancreatic cancer	0.00011	0.00052	CcSEcCtD
Furosemide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000109	0.000518	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000108	0.000514	CcSEcCtD
Furosemide—Anorexia—Epirubicin—pancreatic cancer	0.000108	0.000511	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—pancreatic cancer	0.000107	0.000506	CcSEcCtD
Furosemide—Vomiting—Docetaxel—pancreatic cancer	0.000106	0.000505	CcSEcCtD
Furosemide—Rash—Docetaxel—pancreatic cancer	0.000105	0.000501	CcSEcCtD
Furosemide—Hypotension—Epirubicin—pancreatic cancer	0.000105	0.000501	CcSEcCtD
Furosemide—Dermatitis—Docetaxel—pancreatic cancer	0.000105	0.0005	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—pancreatic cancer	0.000105	0.0005	CcSEcCtD
Furosemide—Headache—Docetaxel—pancreatic cancer	0.000105	0.000498	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000104	0.000496	CcSEcCtD
Furosemide—Shock—Doxorubicin—pancreatic cancer	0.000103	0.000488	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000102	0.000486	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000102	0.000485	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—pancreatic cancer	0.000101	0.000482	CcSEcCtD
Furosemide—Paraesthesia—Epirubicin—pancreatic cancer	0.000101	0.000481	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000101	0.000479	CcSEcCtD
Furosemide—Somnolence—Epirubicin—pancreatic cancer	0.0001	0.000476	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—pancreatic cancer	9.95e-05	0.000473	CcSEcCtD
Furosemide—Nausea—Docetaxel—pancreatic cancer	9.94e-05	0.000472	CcSEcCtD
Furosemide—Decreased appetite—Epirubicin—pancreatic cancer	9.81e-05	0.000466	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—pancreatic cancer	9.75e-05	0.000463	CcSEcCtD
Furosemide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.74e-05	0.000463	CcSEcCtD
Furosemide—Fatigue—Epirubicin—pancreatic cancer	9.73e-05	0.000462	CcSEcCtD
Furosemide—Constipation—Epirubicin—pancreatic cancer	9.65e-05	0.000458	CcSEcCtD
Furosemide—Pain—Epirubicin—pancreatic cancer	9.65e-05	0.000458	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—pancreatic cancer	9.37e-05	0.000445	CcSEcCtD
Furosemide—Feeling abnormal—Epirubicin—pancreatic cancer	9.3e-05	0.000442	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—pancreatic cancer	9.28e-05	0.000441	CcSEcCtD
Furosemide—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.23e-05	0.000438	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—pancreatic cancer	9.07e-05	0.000431	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.01e-05	0.000428	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—pancreatic cancer	9e-05	0.000427	CcSEcCtD
Furosemide—Urticaria—Epirubicin—pancreatic cancer	8.96e-05	0.000426	CcSEcCtD
Furosemide—Pain—Doxorubicin—pancreatic cancer	8.93e-05	0.000424	CcSEcCtD
Furosemide—Constipation—Doxorubicin—pancreatic cancer	8.93e-05	0.000424	CcSEcCtD
Furosemide—Abdominal pain—Epirubicin—pancreatic cancer	8.92e-05	0.000424	CcSEcCtD
Furosemide—Body temperature increased—Epirubicin—pancreatic cancer	8.92e-05	0.000424	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—pancreatic cancer	8.6e-05	0.000409	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.54e-05	0.000405	CcSEcCtD
Furosemide—Hypersensitivity—Epirubicin—pancreatic cancer	8.31e-05	0.000395	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—pancreatic cancer	8.29e-05	0.000394	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—pancreatic cancer	8.25e-05	0.000392	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—pancreatic cancer	8.25e-05	0.000392	CcSEcCtD
Furosemide—Asthenia—Epirubicin—pancreatic cancer	8.09e-05	0.000384	CcSEcCtD
Furosemide—Pruritus—Epirubicin—pancreatic cancer	7.98e-05	0.000379	CcSEcCtD
Furosemide—Diarrhoea—Epirubicin—pancreatic cancer	7.72e-05	0.000367	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—pancreatic cancer	7.69e-05	0.000365	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—pancreatic cancer	7.49e-05	0.000356	CcSEcCtD
Furosemide—Dizziness—Epirubicin—pancreatic cancer	7.46e-05	0.000354	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—pancreatic cancer	7.39e-05	0.000351	CcSEcCtD
Furosemide—Vomiting—Epirubicin—pancreatic cancer	7.17e-05	0.000341	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—pancreatic cancer	7.14e-05	0.000339	CcSEcCtD
Furosemide—Rash—Epirubicin—pancreatic cancer	7.11e-05	0.000338	CcSEcCtD
Furosemide—Dermatitis—Epirubicin—pancreatic cancer	7.11e-05	0.000338	CcSEcCtD
Furosemide—Headache—Epirubicin—pancreatic cancer	7.07e-05	0.000336	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—pancreatic cancer	6.9e-05	0.000328	CcSEcCtD
Furosemide—Nausea—Epirubicin—pancreatic cancer	6.7e-05	0.000318	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—pancreatic cancer	6.64e-05	0.000315	CcSEcCtD
Furosemide—Rash—Doxorubicin—pancreatic cancer	6.58e-05	0.000313	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—pancreatic cancer	6.58e-05	0.000312	CcSEcCtD
Furosemide—Headache—Doxorubicin—pancreatic cancer	6.54e-05	0.000311	CcSEcCtD
Furosemide—Nausea—Doxorubicin—pancreatic cancer	6.2e-05	0.000294	CcSEcCtD
Furosemide—CA14—Metabolism—GCG—pancreatic cancer	3.7e-05	0.00135	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—CXCL8—pancreatic cancer	3.65e-05	0.00133	CbGpPWpGaD
Furosemide—PGD—Metabolism—CD44—pancreatic cancer	3.63e-05	0.00133	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GCG—pancreatic cancer	3.61e-05	0.00132	CbGpPWpGaD
Furosemide—CA6—Metabolism—GCG—pancreatic cancer	3.61e-05	0.00132	CbGpPWpGaD
Furosemide—CA9—Metabolism—TYMP—pancreatic cancer	3.6e-05	0.00132	CbGpPWpGaD
Furosemide—CA4—Metabolism—GLP1R—pancreatic cancer	3.59e-05	0.00131	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	3.55e-05	0.0013	CbGpPWpGaD
Furosemide—CA4—Metabolism—DPYD—pancreatic cancer	3.53e-05	0.00129	CbGpPWpGaD
Furosemide—CA7—Metabolism—CD44—pancreatic cancer	3.51e-05	0.00129	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CD44—pancreatic cancer	3.51e-05	0.00129	CbGpPWpGaD
Furosemide—PGD—Metabolism—GCG—pancreatic cancer	3.48e-05	0.00127	CbGpPWpGaD
Furosemide—CA14—Metabolism—STK11—pancreatic cancer	3.48e-05	0.00127	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.47e-05	0.00127	CbGpPWpGaD
Furosemide—CA2—Metabolism—GLP1R—pancreatic cancer	3.44e-05	0.00126	CbGpPWpGaD
Furosemide—PGD—Disease—SMAD4—pancreatic cancer	3.42e-05	0.00125	CbGpPWpGaD
Furosemide—CA5A—Metabolism—STK11—pancreatic cancer	3.39e-05	0.00124	CbGpPWpGaD
Furosemide—CA6—Metabolism—STK11—pancreatic cancer	3.39e-05	0.00124	CbGpPWpGaD
Furosemide—CA2—Metabolism—DPYD—pancreatic cancer	3.38e-05	0.00124	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GCG—pancreatic cancer	3.37e-05	0.00123	CbGpPWpGaD
Furosemide—CA7—Metabolism—GCG—pancreatic cancer	3.37e-05	0.00123	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.36e-05	0.00123	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC2A2—pancreatic cancer	3.35e-05	0.00123	CbGpPWpGaD
Furosemide—PGD—Disease—HES1—pancreatic cancer	3.34e-05	0.00122	CbGpPWpGaD
Furosemide—CA1—Metabolism—GLP1R—pancreatic cancer	3.3e-05	0.00121	CbGpPWpGaD
Furosemide—PGD—Metabolism—STK11—pancreatic cancer	3.27e-05	0.0012	CbGpPWpGaD
Furosemide—CA12—Metabolism—CD44—pancreatic cancer	3.25e-05	0.00119	CbGpPWpGaD
Furosemide—CA1—Metabolism—DPYD—pancreatic cancer	3.24e-05	0.00119	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC2A2—pancreatic cancer	3.21e-05	0.00118	CbGpPWpGaD
Furosemide—CA5B—Metabolism—STK11—pancreatic cancer	3.16e-05	0.00116	CbGpPWpGaD
Furosemide—CA7—Metabolism—STK11—pancreatic cancer	3.16e-05	0.00116	CbGpPWpGaD
Furosemide—CA12—Metabolism—GCG—pancreatic cancer	3.12e-05	0.00114	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC2A2—pancreatic cancer	3.08e-05	0.00113	CbGpPWpGaD
Furosemide—CA14—Metabolism—TYMS—pancreatic cancer	2.99e-05	0.0011	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—VEGFA—pancreatic cancer	2.96e-05	0.00108	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	2.95e-05	0.00108	CbGpPWpGaD
Furosemide—CA12—Metabolism—STK11—pancreatic cancer	2.93e-05	0.00107	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—STAT3—pancreatic cancer	2.93e-05	0.00107	CbGpPWpGaD
Furosemide—PGD—Disease—TERT—pancreatic cancer	2.93e-05	0.00107	CbGpPWpGaD
Furosemide—CA5A—Metabolism—TYMS—pancreatic cancer	2.92e-05	0.00107	CbGpPWpGaD
Furosemide—CA6—Metabolism—TYMS—pancreatic cancer	2.92e-05	0.00107	CbGpPWpGaD
Furosemide—CA9—Metabolism—GLP1R—pancreatic cancer	2.9e-05	0.00106	CbGpPWpGaD
Furosemide—CA9—Metabolism—DPYD—pancreatic cancer	2.85e-05	0.00104	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA5—pancreatic cancer	2.85e-05	0.00104	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	2.82e-05	0.00103	CbGpPWpGaD
Furosemide—PGD—Metabolism—TYMS—pancreatic cancer	2.81e-05	0.00103	CbGpPWpGaD
Furosemide—PGD—Disease—HIF1A—pancreatic cancer	2.8e-05	0.00102	CbGpPWpGaD
Furosemide—PGD—Disease—TSC2—pancreatic cancer	2.79e-05	0.00102	CbGpPWpGaD
Furosemide—PGD—Disease—APOE—pancreatic cancer	2.73e-05	0.001	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TYMS—pancreatic cancer	2.72e-05	0.000996	CbGpPWpGaD
Furosemide—CA7—Metabolism—TYMS—pancreatic cancer	2.72e-05	0.000996	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC2A2—pancreatic cancer	2.71e-05	0.000991	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PPP2R5B—pancreatic cancer	2.69e-05	0.000985	CbGpPWpGaD
Furosemide—CA4—Metabolism—CD44—pancreatic cancer	2.59e-05	0.000949	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	2.54e-05	0.000928	CbGpPWpGaD
Furosemide—CA12—Metabolism—TYMS—pancreatic cancer	2.52e-05	0.000923	CbGpPWpGaD
Furosemide—PGD—Disease—NOTCH1—pancreatic cancer	2.52e-05	0.000923	CbGpPWpGaD
Furosemide—CA4—Metabolism—GCG—pancreatic cancer	2.49e-05	0.00091	CbGpPWpGaD
Furosemide—CA2—Metabolism—CD44—pancreatic cancer	2.49e-05	0.00091	CbGpPWpGaD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	2.47e-05	0.000904	CbGpPWpGaD
Furosemide—PGD—Disease—EGF—pancreatic cancer	2.44e-05	0.000892	CbGpPWpGaD
Furosemide—CA14—Metabolism—APOE—pancreatic cancer	2.43e-05	0.000891	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—pancreatic cancer	2.4e-05	0.000878	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—pancreatic cancer	2.4e-05	0.000878	CbGpPWpGaD
Furosemide—CA2—Metabolism—GCG—pancreatic cancer	2.38e-05	0.000873	CbGpPWpGaD
Furosemide—CA1—Metabolism—CD44—pancreatic cancer	2.38e-05	0.000873	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOE—pancreatic cancer	2.37e-05	0.000868	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOE—pancreatic cancer	2.37e-05	0.000868	CbGpPWpGaD
Furosemide—CA4—Metabolism—STK11—pancreatic cancer	2.34e-05	0.000856	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOE—pancreatic cancer	2.29e-05	0.000837	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	2.29e-05	0.000837	CbGpPWpGaD
Furosemide—CA1—Metabolism—GCG—pancreatic cancer	2.29e-05	0.000837	CbGpPWpGaD
Furosemide—CA2—Metabolism—STK11—pancreatic cancer	2.24e-05	0.00082	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—pancreatic cancer	2.24e-05	0.000819	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOE—pancreatic cancer	2.21e-05	0.00081	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOE—pancreatic cancer	2.21e-05	0.00081	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TGFB1—pancreatic cancer	2.2e-05	0.000806	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CG—pancreatic cancer	2.2e-05	0.000804	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CD—pancreatic cancer	2.17e-05	0.000793	CbGpPWpGaD
Furosemide—CA1—Metabolism—STK11—pancreatic cancer	2.15e-05	0.000787	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CG—pancreatic cancer	2.14e-05	0.000783	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CG—pancreatic cancer	2.14e-05	0.000783	CbGpPWpGaD
Furosemide—CA14—Metabolism—PPARG—pancreatic cancer	2.12e-05	0.000776	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—pancreatic cancer	2.11e-05	0.000774	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	2.1e-05	0.000768	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD44—pancreatic cancer	2.1e-05	0.000767	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PPARG—pancreatic cancer	2.07e-05	0.000756	CbGpPWpGaD
Furosemide—CA6—Metabolism—PPARG—pancreatic cancer	2.07e-05	0.000756	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CG—pancreatic cancer	2.06e-05	0.000756	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—pancreatic cancer	2.05e-05	0.000751	CbGpPWpGaD
Furosemide—CA4—Metabolism—TYMS—pancreatic cancer	2.01e-05	0.000736	CbGpPWpGaD
Furosemide—CA9—Metabolism—GCG—pancreatic cancer	2.01e-05	0.000735	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CG—pancreatic cancer	2e-05	0.000731	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CG—pancreatic cancer	2e-05	0.000731	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPARG—pancreatic cancer	1.99e-05	0.000729	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CD—pancreatic cancer	1.93e-05	0.000707	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPARG—pancreatic cancer	1.93e-05	0.000706	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPARG—pancreatic cancer	1.93e-05	0.000706	CbGpPWpGaD
Furosemide—CA2—Metabolism—TYMS—pancreatic cancer	1.93e-05	0.000706	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	1.91e-05	0.000698	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CB—pancreatic cancer	1.89e-05	0.000692	CbGpPWpGaD
Furosemide—CA9—Metabolism—STK11—pancreatic cancer	1.89e-05	0.000692	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CD—pancreatic cancer	1.88e-05	0.000689	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CD—pancreatic cancer	1.88e-05	0.000689	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—pancreatic cancer	1.87e-05	0.000685	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CG—pancreatic cancer	1.85e-05	0.000678	CbGpPWpGaD
Furosemide—CA1—Metabolism—TYMS—pancreatic cancer	1.85e-05	0.000677	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CD—pancreatic cancer	1.82e-05	0.000664	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.8e-05	0.00066	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARG—pancreatic cancer	1.79e-05	0.000654	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	1.78e-05	0.000651	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	1.76e-05	0.000644	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CD—pancreatic cancer	1.76e-05	0.000643	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CD—pancreatic cancer	1.76e-05	0.000643	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CB—pancreatic cancer	1.68e-05	0.000616	CbGpPWpGaD
Furosemide—PGD—Disease—CTNNB1—pancreatic cancer	1.67e-05	0.000613	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—pancreatic cancer	1.67e-05	0.00061	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CB—pancreatic cancer	1.64e-05	0.0006	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CB—pancreatic cancer	1.64e-05	0.0006	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—pancreatic cancer	1.64e-05	0.000599	CbGpPWpGaD
Furosemide—PGD—Disease—PTEN—pancreatic cancer	1.63e-05	0.000598	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CD—pancreatic cancer	1.63e-05	0.000596	CbGpPWpGaD
Furosemide—CA9—Metabolism—TYMS—pancreatic cancer	1.63e-05	0.000595	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—pancreatic cancer	1.62e-05	0.000595	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—pancreatic cancer	1.62e-05	0.000595	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD44—pancreatic cancer	1.61e-05	0.00059	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CB—pancreatic cancer	1.58e-05	0.000579	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—pancreatic cancer	1.57e-05	0.000574	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—pancreatic cancer	1.57e-05	0.000574	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	1.56e-05	0.000573	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA1—pancreatic cancer	1.56e-05	0.000571	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CB—pancreatic cancer	1.53e-05	0.00056	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CB—pancreatic cancer	1.53e-05	0.00056	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—pancreatic cancer	1.52e-05	0.000555	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—pancreatic cancer	1.52e-05	0.000555	CbGpPWpGaD
Furosemide—PGD—Disease—SRC—pancreatic cancer	1.51e-05	0.000554	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—pancreatic cancer	1.5e-05	0.00055	CbGpPWpGaD
Furosemide—ALB—Metabolism—PRSS1—pancreatic cancer	1.48e-05	0.000542	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CG—pancreatic cancer	1.48e-05	0.00054	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—pancreatic cancer	1.46e-05	0.000534	CbGpPWpGaD
Furosemide—PGD—Disease—NRAS—pancreatic cancer	1.46e-05	0.000533	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTEN—pancreatic cancer	1.45e-05	0.000532	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA2—pancreatic cancer	1.45e-05	0.000532	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—pancreatic cancer	1.42e-05	0.000521	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CB—pancreatic cancer	1.42e-05	0.000519	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTEN—pancreatic cancer	1.42e-05	0.000519	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTEN—pancreatic cancer	1.42e-05	0.000519	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CG—pancreatic cancer	1.42e-05	0.000518	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—pancreatic cancer	1.41e-05	0.000514	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTEN—pancreatic cancer	1.37e-05	0.0005	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—pancreatic cancer	1.37e-05	0.0005	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	1.36e-05	0.000499	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CG—pancreatic cancer	1.36e-05	0.000497	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—pancreatic cancer	1.36e-05	0.000497	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—pancreatic cancer	1.35e-05	0.000495	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—pancreatic cancer	1.33e-05	0.000486	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTEN—pancreatic cancer	1.32e-05	0.000484	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTEN—pancreatic cancer	1.32e-05	0.000484	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—pancreatic cancer	1.32e-05	0.000484	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—pancreatic cancer	1.31e-05	0.000479	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CD—pancreatic cancer	1.3e-05	0.000475	CbGpPWpGaD
Furosemide—ALB—Metabolism—ARG2—pancreatic cancer	1.28e-05	0.00047	CbGpPWpGaD
Furosemide—PGD—Disease—KRAS—pancreatic cancer	1.25e-05	0.000459	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CD—pancreatic cancer	1.24e-05	0.000455	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTEN—pancreatic cancer	1.23e-05	0.000449	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CG—pancreatic cancer	1.19e-05	0.000437	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CD—pancreatic cancer	1.19e-05	0.000437	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—pancreatic cancer	1.15e-05	0.000422	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—pancreatic cancer	1.15e-05	0.000421	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CB—pancreatic cancer	1.13e-05	0.000414	CbGpPWpGaD
Furosemide—ALB—Metabolism—TYMP—pancreatic cancer	1.12e-05	0.000411	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—pancreatic cancer	1.12e-05	0.00041	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.09e-05	0.0004	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CB—pancreatic cancer	1.08e-05	0.000397	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—pancreatic cancer	1.07e-05	0.000393	CbGpPWpGaD
Furosemide—PGD—Disease—HRAS—pancreatic cancer	1.07e-05	0.00039	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.06e-05	0.00039	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CD—pancreatic cancer	1.05e-05	0.000384	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CB—pancreatic cancer	1.04e-05	0.000381	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAU—pancreatic cancer	1.03e-05	0.000377	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—pancreatic cancer	1.03e-05	0.000377	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—pancreatic cancer	1.03e-05	0.000375	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—pancreatic cancer	1e-05	0.000366	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—pancreatic cancer	1e-05	0.000366	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTEN—pancreatic cancer	9.77e-06	0.000358	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	9.77e-06	0.000358	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—pancreatic cancer	9.64e-06	0.000353	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—pancreatic cancer	9.41e-06	0.000344	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTEN—pancreatic cancer	9.37e-06	0.000343	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—pancreatic cancer	9.33e-06	0.000342	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—pancreatic cancer	9.33e-06	0.000342	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.25e-06	0.000339	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CG—pancreatic cancer	9.17e-06	0.000336	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CB—pancreatic cancer	9.14e-06	0.000335	CbGpPWpGaD
Furosemide—ALB—Hemostasis—EGF—pancreatic cancer	9.07e-06	0.000332	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—pancreatic cancer	9.06e-06	0.000331	CbGpPWpGaD
Furosemide—ALB—Metabolism—GLP1R—pancreatic cancer	9.04e-06	0.000331	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTEN—pancreatic cancer	8.98e-06	0.000329	CbGpPWpGaD
Furosemide—ALB—Metabolism—DPYD—pancreatic cancer	8.89e-06	0.000326	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—pancreatic cancer	8.65e-06	0.000316	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A2—pancreatic cancer	8.44e-06	0.000309	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—pancreatic cancer	8.38e-06	0.000307	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.35e-06	0.000306	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	8.31e-06	0.000304	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—pancreatic cancer	8.17e-06	0.000299	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—pancreatic cancer	8.17e-06	0.000299	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CD—pancreatic cancer	8.07e-06	0.000295	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.06e-06	0.000295	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTEN—pancreatic cancer	7.9e-06	0.000289	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—pancreatic cancer	7.88e-06	0.000288	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—pancreatic cancer	7.62e-06	0.000279	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—pancreatic cancer	7.62e-06	0.000279	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.34e-06	0.000269	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—pancreatic cancer	7.06e-06	0.000259	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CB—pancreatic cancer	7.03e-06	0.000257	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—pancreatic cancer	6.89e-06	0.000252	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	6.79e-06	0.000249	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—pancreatic cancer	6.61e-06	0.000242	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD44—pancreatic cancer	6.54e-06	0.000239	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.4e-06	0.000234	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.34e-06	0.000232	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—pancreatic cancer	6.34e-06	0.000232	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCG—pancreatic cancer	6.27e-06	0.000229	CbGpPWpGaD
Furosemide—ALB—Metabolism—STK11—pancreatic cancer	5.89e-06	0.000216	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SRC—pancreatic cancer	5.63e-06	0.000206	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—pancreatic cancer	5.63e-06	0.000206	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—pancreatic cancer	5.57e-06	0.000204	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.53e-06	0.000202	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—pancreatic cancer	5.49e-06	0.000201	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NRAS—pancreatic cancer	5.42e-06	0.000198	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—pancreatic cancer	5.4e-06	0.000198	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—pancreatic cancer	5.18e-06	0.00019	CbGpPWpGaD
Furosemide—ALB—Metabolism—TYMS—pancreatic cancer	5.07e-06	0.000186	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—pancreatic cancer	5.04e-06	0.000184	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KRAS—pancreatic cancer	4.66e-06	0.000171	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—pancreatic cancer	4.55e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—pancreatic cancer	4.29e-06	0.000157	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—pancreatic cancer	4.15e-06	0.000152	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—pancreatic cancer	4.12e-06	0.000151	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HRAS—pancreatic cancer	3.96e-06	0.000145	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.9e-06	0.000143	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CG—pancreatic cancer	3.72e-06	0.000136	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—pancreatic cancer	3.59e-06	0.000131	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—pancreatic cancer	3.5e-06	0.000128	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CD—pancreatic cancer	3.27e-06	0.00012	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CB—pancreatic cancer	2.85e-06	0.000104	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—pancreatic cancer	2.82e-06	0.000103	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTEN—pancreatic cancer	2.46e-06	9.02e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—pancreatic cancer	1.74e-06	6.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—pancreatic cancer	1.42e-06	5.2e-05	CbGpPWpGaD
